- Home
- Publications
- Publication Search
- Publication Details
Title
Personalised medicine for multiple sclerosis care
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 3, Pages 362-369
Publisher
SAGE Publications
Online
2016-09-27
DOI
10.1177/1352458516672017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
- (2016) Sudarshini Ramanathan et al. AUTOIMMUNITY REVIEWS
- TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
- (2016) C Alvarez-Gonzalez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A pharmacogenetic study implicatesSLC9a9in multiple sclerosis disease activity
- (2015) Federica Esposito et al. ANNALS OF NEUROLOGY
- Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
- (2015) Tomas Kalincik et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid proteomics in multiple sclerosis
- (2015) Ann C. Kroksveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- (2015) Mar Tintore et al. BRAIN
- Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β
- (2015) Harald Hegen et al. Expert Opinion on Drug Metabolism & Toxicology
- Forecasting the Incidence of Dementia and Dementia-Related Outpatient Visits With Google Trends: Evidence From Taiwan
- (2015) Ho-Wei Wang et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up
- (2015) A. Petzold JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Biologic efficacy optimization—a step towards personalized medicine
- (2015) Patrick D. W. Kiely RHEUMATOLOGY
- Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
- (2015) E. T. Cirulli et al. SCIENCE
- Unmet needs of multiple sclerosis patients in the community
- (2015) Roisin Lonergan et al. Multiple Sclerosis and Related Disorders
- Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort
- (2014) Mohammad Ehsanul Karim et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses
- (2014) G. J. SILVERMAN et al. JOURNAL OF RHEUMATOLOGY
- Multiple sclerosis genetics
- (2014) Stephen Sawcer et al. LANCET NEUROLOGY
- Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis
- (2014) Sandra Amor et al. Multiple Sclerosis Journal
- Economic costs associated with an MS relapse
- (2014) K. O׳Connell et al. Multiple Sclerosis and Related Disorders
- Objectively Quantified Physical Activity in Persons With Multiple Sclerosis
- (2013) Rachel E. Klaren et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world
- (2013) M. D. Goldman et al. NEUROLOGY
- Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
- (2012) Joanna Kitley et al. BRAIN
- Network Analysis of Randomized Controlled Trials in Multiple Sclerosis
- (2012) Elias Zintzaras et al. CLINICAL THERAPEUTICS
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
- (2011) S Vosslamber et al. GENES AND IMMUNITY
- Population Pharmacokinetics of Fingolimod Phosphate in Healthy Participants
- (2011) Kai Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection
- (2010) K Vandenbroeck et al. GENES AND IMMUNITY
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Brainstem lesions in clinically isolated syndromes
- (2010) M. Tintore et al. NEUROLOGY
- Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis
- (2009) A. Uzawa et al. EUROPEAN JOURNAL OF NEUROLOGY
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
- (2008) C Potter et al. ANNALS OF THE RHEUMATIC DISEASES
- Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis
- (2008) Esther Byun et al. ARCHIVES OF NEUROLOGY
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
- Review: Neutralizing antibodies against interferon-beta
- (2008) Per Soelberg Sorensen Therapeutic Advances in Neurological Disorders
- In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
- (2007) A Sominanda et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started